
MDA – Medical Decision Alliance secures €3.3 million in seed funding to develop comprehensive surgical support systems
News Article
- Successful seed financing round led by High-Tech Gründerfonds (HTGF) with additional private investors and entrepreneurs
- Qualified MDA team systematically captures the experience and knowledge of the world’s leading surgeons and uses it to develop comprehensive and globally available assistance systems for the operating theatre.
- Already three partnerships with leading global medical technology companies to make surgical robots smarter.
Healthcare start-up MDA – Medical Decision Alliance has raised EUR 3.3 million in seed financing. The founding team, led by experienced life science entrepreneurs Dr Gunter Trojandt, Annett Christ and Daniel Bauer, has developed special software solutions that can be used to record the surgical techniques and decision-making routines of leading surgeons in detail and transfer them to AI-based assistance systems.
Making surgical robots smarter, pooling distributed knowledge.
Surgical robots and other specialised systems are increasingly being used in today’s surgery to improve the precision of procedures. However, individual decisions during surgery remain at the surgeon’s discretion and may be incorrect in some cases. Based on the decades of experience of renowned surgeons and in collaboration with leading manufacturers of robotic surgical systems, MDA is developing decision-making algorithms that suggest the most appropriate workflow for a wide range of patient situations.
In the future, surgical teams will be supported by intelligent algorithms as if the most experienced surgeon in the field were sitting right next to them. This will not only benefit the learning teams, but also the patients.
Making surgical knowledge available worldwide
A key priority is the education and training of the next generation of surgeons. MDA is committed to sharing expert knowledge through programmatic training solutions that are always up to date and available 24/7 – the digitalisation of surgical education.
“Together with MDA, we have digitised all key aspects of our surgical skills and developed an AI-based workflow engine called Virtual Proctor. Other clinics and doctors can now access it and benefit from our 20 years of experience – as far as I know there is no other system like it,” says Professor Markus Graefen, Medical Director of the Martini-Klinik at UKE GmbH, the Prostate Cancer Centre at the University Medical Centre Hamburg-Eppendorf.
MDA as a partner for innovative medical technology companies
In addition to robotics, which is the current focus of the MDA, the Virtual Proctor will also serve as a digital platform for interested MedTech partners to present their innovative products along specific indications. The focus will also be on the knowledge of experts who already use these products on a daily basis. This makes it easier for new customers to acquire additional expertise, as the Virtual Proctor provides conceptual knowledge, visual and clinically relevant content based on established standards and experience – real added value for clinics.
Dr Lena-Sophie Schütter, Investment Manager at HTGF, comments: “MDA’s well-coordinated team combines experience, expertise and a strong network – qualities that already characterised the success of their previous start-up. Through the structured development of a unique reference database, they are laying the foundation for AI-based training and decision-making algorithms. In this way, they are creating the conditions for greater safety, comparability and cross-clinic standards in robotic surgery – with the aim of providing better care for patients. ”

About MDA – Medical Decision Alliance
MDA was founded in 2023 by Dr Gunter Trojandt, Annett Christ and two business angels, Jozsef Bugovics and Nils Kröber. MDA has a total of 10 employees and is based in Leipzig, Germany. The founding team has been working together for more than 10 years and successfully sold their last joint company, SPI – Surgical Process Institute, to Johnson & Johnson – a leading global manufacturer of medical devices and surgical robots – in 2017.
The focus of SPI and MDA is on the operating room and improving the quality of patient outcomes. All developments are carried out in close collaboration with leading physicians, clinics and medical device companies.
With the capital from the current round of financing, MDA will double the size of its team, recruit additional clinics (knowledge providers) and medical device companies (collaborators), and develop AI-based surgical training and assistance solutions.
About HTGF – High-Tech Gründerfonds
HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing startups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports startups in all phases of their development into international market leaders. HTGF invests in pre-seed and seed phases and can participate significantly in later-stage financing rounds. Across its funds, HTGF has over 2 billion euros under management. Since its inception in 2005, HTGF has financed more than 770 startups and achieved almost 200 successful exits.
Fund investors in the public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital as well as 45 companies and family offices. For more information, please visit HTGF.de or follow us on LinkedIn.
Media contact
High-Tech Gründerfonds Management GmbH
Tobias Jacob, Senior Marketing & Communications Manager
T.: +49 228 – 82300 – 121
t.jacob@htgf.de
Do you want to
mehr erfahren?
I am your contact
for all press inquiries:
Tobias Jacob
More News

nuuEnergy Secures Multi-Million Euro Funding – and Aims to Rethink the Heat Pump Industry as a Premium Quality Provider

Proxima Fusion raises €130M Series A to build world’s first stellarator-based fusion power plant in the 2030s

Mosanna Therapeutics Launches with $80 Million to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea
